These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11502318)

  • 1. Monitoring of large randomised clinical trials: a new approach with Bayesian methods.
    Parmar MK; Griffiths GO; Spiegelhalter DJ; Souhami RL; Altman DG; van der Scheuren E;
    Lancet; 2001 Aug; 358(9279):375-81. PubMed ID: 11502318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee.
    Parmar MK; Spiegelhalter DJ; Freedman LS
    Stat Med; 1994 Jul 15-30; 13(13-14):1297-312. PubMed ID: 7973211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
    Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee.
    Coyle D; Drummond MF
    Clin Oncol (R Coll Radiol); 1997; 9(5):313-21. PubMed ID: 9368727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions.
    Hatton MQ; Martin JE
    Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):356-64. PubMed ID: 20399629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms. CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy.
    Griffiths GO; Parmar MK; Bailey AJ
    Br J Cancer; 1999 Dec; 81(7):1196-205. PubMed ID: 10584882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in clinical trial design: stopping a trial early and the large and simple trial.
    Thom EA; Klebanoff MA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):619-25. PubMed ID: 16150252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing whether to perform a confirmatory randomized clinical trial.
    Parmar MK; Ungerleider RS; Simon R
    J Natl Cancer Inst; 1996 Nov; 88(22):1645-51. PubMed ID: 8931608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
    Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
    Johnson VE; Cook JD
    Clin Trials; 2009 Jun; 6(3):217-26. PubMed ID: 19528131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers].
    Horiot JC
    Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is double data entry necessary? The CHART trials. CHART Steering Committee. Continuous, Hyperfractionated, Accelerated Radiotherapy.
    Gibson D; Harvey AJ; Everett V; Parmar MK
    Control Clin Trials; 1994 Dec; 15(6):482-8. PubMed ID: 7851109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.
    Diamond GA; Kaul S
    J Am Coll Cardiol; 2004 Jun; 43(11):1929-39. PubMed ID: 15172393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Goss G; Paszat L; Newman TE; Evans WK; Browman G
    Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
    Trotti A; Pajak TF; Gwede CK; Paulus R; Cooper J; Forastiere A; Ridge JA; Watkins-Bruner D; Garden AS; Ang KK; Curran W
    Lancet Oncol; 2007 Jul; 8(7):613-24. PubMed ID: 17543584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequentist evaluation of group sequential clinical trial designs.
    Emerson SS; Kittelson JM; Gillen DL
    Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.